RE:RE:Frankly, I think that some old-timers got caught this weekinthno wrote:
to bad you could not just let it go. You are not the omnipotent know all. This is from the letter to shareholders HR+/HER2- Breast Cancer Program: Randomized Phase 2 Data Readout Expected in Q4 2022 I am happy to report that our BRACELET-1 trial is about to complete enrollment. We remain on track to announce top-line data from the study in Q4 2022.
Let Noteable bark he is very good!